Conventional T1 and T2 weighted MRI are ubiquitously used to diagnose and monitor disease progression in multiple sclerosis, but are only sensitive to later-stage inflammatory lesions and atrophy. Imaging biomarkers sensitive to tissue changes earlier in disease pathology may have significant implications in the diagnosis and prognosis of MS. Quantitative magnetization transfer (qMT) and chemical exchange saturation transfer (CEST) MRI have shown sensitivity to macromolecules and tissue biochemistry, respectively. In this work, we investigate quantitatively derived metrics from qMT and CEST as potential biomarkers for pathological changes which precede lesion formation.
This abstract and the presentation materials are available to members only; a login is required.